Additionally, other m6A regulators, YTHDF1 and ALKBH5, were also engaged in chemoresistance (including adriamycin, cisplatin, and olaparib) by enhancing DNA damage repair in breast cancer (BC) [63, 64]. Here, ALKBH5 is linked to breast cancer.